livehealth.store

TerSera Therapeutics recalls

TerSera Therapeutics has 1 recall on record with the FDA and USDA, the earliest in 2026 and the latest reported on 7 Oct 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is temperature abuse.

Total recalls1since 2026

Last 12 months1reported

Class I00% of total

Ongoing1latest 7 Oct 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 1

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why tersera therapeutics is recalled

Temperature Abuse1100%

By year

20261100%

Ongoing tersera therapeutics recalls

1 active

Reported	Class	Recall	Company	Reason	Where
7 Oct 2026Drug	CLASS II	Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe recalledZoladex	TerSera Therapeutics	Temperature Abuse	Nationwide

All tersera therapeutics recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
7 Oct 2026Drug	CLASS II	Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe recalledZoladex	TerSera Therapeutics	Temperature Abuse	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.